Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Intern Med ; 51(6): 655-7, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22449679

RESUMO

Hemophagocytic lymphohistiocytosis (HLH) is a rare condition with high mortality. We report a case of a 74-year-old woman with rheumatoid arthritis who developed HLH secondary to pyelonephritis due to Escherichia coli infection following infliximab treatment. Bone marrow aspiration showed proliferation of histiocytes with hemophagocytosis. The patient died despite treatment with intravenous antibiotics intravenous methylprednisolone and intravenous immunoglobulin. Cytokine levels were measured and are discussed.


Assuntos
Anticorpos Monoclonais/efeitos adversos , Antirreumáticos/efeitos adversos , Artrite Reumatoide/complicações , Infecções por Escherichia coli/complicações , Imunossupressores/efeitos adversos , Linfo-Histiocitose Hemofagocítica/etiologia , Pielonefrite/complicações , Idoso , Antibacterianos/uso terapêutico , Anticorpos Monoclonais/uso terapêutico , Antirreumáticos/uso terapêutico , Artrite Reumatoide/tratamento farmacológico , Artrite Reumatoide/imunologia , Medula Óssea/patologia , Infecções por Escherichia coli/tratamento farmacológico , Evolução Fatal , Feminino , Histiócitos/patologia , Humanos , Hospedeiro Imunocomprometido , Imunoglobulinas Intravenosas/uso terapêutico , Imunossupressores/uso terapêutico , Infliximab , Meropeném , Metilprednisolona/uso terapêutico , Pielonefrite/tratamento farmacológico , Tienamicinas/uso terapêutico
4.
Gan To Kagaku Ryoho ; 38(3): 489-92, 2011 Mar.
Artigo em Japonês | MEDLINE | ID: mdl-21403462

RESUMO

A 64-year-old male consulted our clinic due to pancytopenia. Bone marrow appearance was consistent with multiple myeloma and an IgG-κ type M component was detected on electroimmuno-diffusion of urine. MP therapy (melphalan 2 mg/ day, prednisolone 10 mg/day) was started on an outpatient basis, but the pancytopenia worsened. The patient was then admitted to our hospital, and a course of Velcade therapy (bortezomib 2. 4 mg day 1, 4, 8, 11) was started. After a course of Velcade therapy, side effects such as gastrointestinal dysfunction appeared. A month after the disruption of the chomotherapy, the patient suddenly died. The autopsy report stated that the atrial blood showed 19, 200/µL of white blood cells and 39% of plasma cells, and a slight infiltration was found in liver, kidney and vessels. Two days before death, the blood picture showed no plasma cells. The cause of death was considered to be aggressive multiple myeloma.


Assuntos
Mieloma Múltiplo/patologia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Autopsia , Biópsia , Ácidos Borônicos/uso terapêutico , Bortezomib , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Evolução Fatal , Humanos , Masculino , Melfalan/administração & dosagem , Melfalan/uso terapêutico , Pessoa de Meia-Idade , Mieloma Múltiplo/tratamento farmacológico , Invasividade Neoplásica , Prednisolona/administração & dosagem , Prednisolona/uso terapêutico , Pirazinas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA